BIOMAT Database Logo BIOMAT Database Logo

ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling. 2024

Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Department of Urology, Shanghai Fifth People's Hospital, Fudan University, No. 801, Heqing Road, Minhang District, Shanghai, 200240, PR China. Electronic address: 21211290008@m.fudan.edu.cn.

ANP32B is a histone chaperone that interacts with various transcription factors that regulate cancer cell proliferation, immigration, and apoptosis. c-Myc, a well-known oncogenic protein, is a principal player in the initiation and progression of prostate cancer (PC). The means by which ANP32B and c-Myc act remain unknown. We downloaded clinical data from the GEO, TCGA, and other databases to explore ANP32B expression and its effects on the survival of PC and normal tissues. ANP32B-knockdown cell lines were used to evaluate how ANP32B affected cell proliferation in vitro and in vivo. Gene set enrichment analysis and RNAseq were employed to define how ANP32B regulated PC pathways. Immunohistochemical measures were used to detect the expression levels of relevant proteins in xenografts and PC tissues. ANP32B expression increased in PC tissues; ANP32B knockdown inhibited cell growth but this was rescued by c-Myc signaling. ANP32B is thus a PC oncogene and may serve as a valuable therapeutic target when seeking to treat PC.

UI MeSH Term Description Entries
D008297 Male Males
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016271 Proto-Oncogene Proteins c-myc Basic helix-loop-helix transcription factors encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis. L-myc Proteins,N-myc Proteins,c-myc Proteins,myc Proto-Oncogene Proteins,p62(c-myc),Proto-Oncogene Products c-myc,Proto-Oncogene Proteins myc,myc Proto-Oncogene Product p62,p62 c-myc,L myc Proteins,N myc Proteins,Proteins myc, Proto-Oncogene,Proto Oncogene Products c myc,Proto Oncogene Proteins c myc,Proto Oncogene Proteins myc,Proto-Oncogene Proteins, myc,c myc Proteins,myc Proto Oncogene Product p62,myc Proto Oncogene Proteins,myc, Proto-Oncogene Proteins,p62 c myc
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
July 2023, Molecular carcinogenesis,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway.
January 2022, Drug design, development and therapy,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
March 2000, Cancer research,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Inhibition of OTUB2 suppresses colorectal cancer cell growth by regulating β-Catenin signaling.
January 2023, American journal of cancer research,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.
February 2015, The Journal of biological chemistry,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling.
January 2020, OncoTargets and therapy,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc.
January 2018, Gastroenterology research and practice,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Gambogenic acid suppresses bladder cancer cells growth and metastasis by regulating NF-κB signaling.
November 2020, Chemical biology & drug design,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
ANP32B promotes lung cancer progression by regulating VDAC1.
April 2023, Gene,
Cheng Zhou, and Hangbin Ma, and Wandong Yu, and Yinghao Zhou, and Xuehu Zhang, and Yibo Meng, and Chenchen Chen, and Jun Zhang, and Guowei Shi
Antisense c-myc retroviral vector suppresses established human prostate cancer.
March 1998, Human gene therapy,
Copied contents to your clipboard!